drugset / Trial / NCT02385266
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Phase 4
Terminated
24 enrolled
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of D-Cycloserine versus placebo treatment in reducing pain from urological chronic pelvic pain syndrome (UCPPS).
Timeline
- Start
- 2013-09
- Primary completion
- 2016-05
- Completion
- 2016-06
Outcome
Outcome not reported
Stopped (Enrollment): “The study was closed due to recruitment limitations”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cycloserine | Small molecule | 200 mg | — |